Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Carolin Pozder, Elles M. Screever, A. Rogier van der Velde, Herman H. Silljé, Janne Suwijn, Saskia de Rond, Marcus E. Kleber, Graciela Delgado, Jan Jacob Schuringa, Wiek H. van Gilst, Wouter C. Meijers, Winfried März & Rudolf A. de Boer. (2023) Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance. International Journal of Molecular Sciences 24:5, pages 4415.
Crossref
Crossref
Wenke Cheng, Georg Fuernau, Steffen Desch, Anne Freund, Hans-Josef Feistritzer, Janine Pöss, Christian Besler, Philipp Lurz, Petra Büttner & Holger Thiele. (2022) Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial. Journal of Clinical Medicine 11:23, pages 7168.
Crossref
Crossref
Janka Franeková, Lenka Hošková & Antonín Jabor. (2022) Galectin‐3 as an independent prognostic factor after heart transplantation. Clinical Transplantation 36:5.
Crossref
Crossref
Aneta Aleksova, Gianfranco Sinagra, Antonio P. Beltrami, Alessandro Pierri, Federico Ferro, Milijana Janjusevic & Giulia Gagno. (2021) Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era. ESC Heart Failure 8:6, pages 4465-4483.
Crossref
Crossref
Wouter C. Meijers, Antoni Bayes‐Genis, Alexandre Mebazaa, Johann Bauersachs, John G.F. Cleland, Andrew J.S. Coats, James L. Januzzi, Alan S. Maisel, Kenneth McDonald, Thomas Mueller, A. Mark Richards, Petar Seferovic, Christian Mueller & Rudolf A. Boer. (2021)
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (
HFA
), European Society of Cardiology (
ESC
)
. European Journal of Heart Failure 23:10, pages 1610-1632.
Crossref
Crossref
Camilo G. Sotomayor, Charlotte A. te Velde-Keyzer, Arjan Diepstra, Marco van Londen, Robert A. Pol, Adrian Post, Rijk O.B. Gans, Ilja M. Nolte, Riemer H.J.A. Slart, Martin H. de Borst, Stefan P. Berger, Ramón Rodrigo, Gerjan J. Navis, Rudolf A. de Boer & Stephan J.L. Bakker. (2020) Galectin-3 and Risk of Late Graft Failure in Kidney Transplant Recipients: A 10-year Prospective Cohort Study. Transplantation 105:5, pages 1106-1115.
Crossref
Crossref
Jianli Bi, Vidu Garg & Andrew R. Yates. (2021) Galectin-3 and sST2 as Prognosticators for Heart Failure Requiring Extracorporeal Life Support: Jack n’ Jill. Biomolecules 11:2, pages 166.
Crossref
Crossref
Sofía V. Piguillem, Maria Gamella, Pablo García de Frutos, Montserrat Batlle, Paloma Yáñez‐Sedeño, Germán A. Messina, Martín A. Fernández‐Baldo, Susana Campuzano, María Pedrero & José M. Pingarrón. (2020) Easily Multiplexable Immunoplatform to Assist Heart Failure Diagnosis through Amperometric Determination of Galectin‐3. Electroanalysis 32:12, pages 2775-2785.
Crossref
Crossref
Yesim Akin, Burcu Demirkan, Senay Suljevic & Esra Gucuk Ipek. (2020) Galectin-3: A New Biomarker for Atherosclerosis Management. Angiology 71:10, pages 966-966.
Crossref
Crossref
Mingxing Li, Yong Yuan, Kai Guo, Yi Lao, Xuansheng Huang & Li Feng. (2019) Value of Galectin-3 in Acute Myocardial Infarction. American Journal of Cardiovascular Drugs 20:4, pages 333-342.
Crossref
Crossref
Martin Robert Grübler, Graciela Delgado, Marcus Kleber, Bríain ó. Hartaigh, Rudolf Allert de Boer, Nicolas Verheyen, Martin Keppel, Johannes Schmid, George CM Siontis, Lorenz Räber, Burkert Pieske, Stefan Pilz, Andreas Tomaschitz & Winfried März. (2020) Effect of Galectin 3 on Aldosterone-Associated Risk of Cardiovascular Mortality in Patients Undergoing Coronary Angiography. The American Journal of Cardiology 127, pages 9-15.
Crossref
Crossref
Ziyu Gao, Zhongni Liu, Rui Wang, Yinghong Zheng, Hong Li & Liming Yang. (2020) Galectin-3 Is a Potential Mediator for Atherosclerosis. Journal of Immunology Research 2020, pages 1-11.
Crossref
Crossref
Oliver Dörr, Claudia Walther, Christoph Liebetrau, Till Keller, Thomas Sommer, Niklas Boeder, Matthias Bayer, Pascal Bauer, Helge Möllmann, Luise Gaede, Christian Troidl, Sandra Voss, Timm Bauer, Christian W. Hamm & Holger Nef. (2018) Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip). Clinical Cardiology 41:9, pages 1164-1169.
Crossref
Crossref
Nicolas Clementy, Bruno Garcia, Clémentine André, Arnaud Bisson, Nazih Benhenda, Bertrand Pierre, Anne Bernard, Laurent Fauchier, Eric Piver & Dominique Babuty. (2018) Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure. PLOS ONE 13:8, pages e0201517.
Crossref
Crossref
Carolin Gehlken, Navin Suthahar, Wouter C. Meijers & Rudolf A. de Boer. (2018) Galectin-3 in Heart Failure. Heart Failure Clinics 14:1, pages 75-92.
Crossref
Crossref
T.N.A. (Daniëlle) van den Berg, Wouter C. Meijers, A. Rogier T. Donders, Antonius E. Van Herwaarden, Gerard A. Rongen, Rudolf A. de Boer, Jaap Deinum & Niels P. Riksen. (2017) Plasma galectin-3 concentrations in patients with primary aldosteronism. Journal of Hypertension 35:9, pages 1849-1856.
Crossref
Crossref
Luisa Agnello, Giulia Bivona, Bruna Lo Sasso, Concetta Scazzone, Viviana Bazan, Chiara Bellia & Marcello Ciaccio. (2017) Galectin-3 in acute coronary syndrome. Clinical Biochemistry 50:13-14, pages 797-803.
Crossref
Crossref
Andreea Barcan, Zsuzsanna Suciu & Emese Rapolti. (2017) Monitoring Acute Myocardial Infarction Complicated with Cardiogenic Shock — from the Emergency Room to Coronary Care Units. Journal Of Cardiovascular Emergencies 3:2, pages 61-71.
Crossref
Crossref
Wouter C. Meijers, A. Rogier van der Velde, Anneke C. Muller Kobold, Janneke Dijck-Brouwer, Alan H. Wu, Allan Jaffe & Rudolf A. de Boer. (2017) Variability of biomarkers in patients with chronic heart failure and healthy controls. European Journal of Heart Failure 19:3, pages 357-365.
Crossref
Crossref
Thomas Mueller, Alfons Gegenhuber, Isabella Leitner, Werner Poelz, Meinhard Haltmayer & Benjamin Dieplinger. (2016) Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure. Clinica Chimica Acta 463, pages 158-164.
Crossref
Crossref
A Rogier van der Velde, Wouter C Meijers, Jennifer E Ho, Frank P Brouwers, Michiel Rienstra, Stephan J L Bakker, Anneke C Muller Kobold, Dirk J van Veldhuisen, Wiek H van Gilst, Pim van der Harst & Rudolf A de Boer. (2016) Serial galectin-3 and future cardiovascular disease in the general population. Heart 102:14, pages 1134-1141.
Crossref
Crossref
A. Rogier van der Velde, Chris P.H. Lexis, Wouter C. Meijers, Iwan C. van der Horst, Erik Lipsic, Martin M. Dokter, Dirk J. van Veldhuisen, Pim van der Harst & Rudolf A. de Boer. (2016) Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction. Clinica Chimica Acta 452, pages 50-57.
Crossref
Crossref
Wouter C. Meijers, Rudolf A. de Boer, Dirk J. van Veldhuisen, Tiny Jaarsma, Hans L. Hillege, Alan S. Maisel, Salvatore Di Somma, Adriaan A. Voors & W. Frank Peacock. (2015) Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH. European Journal of Heart Failure 17:12, pages 1271-1282.
Crossref
Crossref
Rudolf A. de Boer, Lori B. Daniels, Alan S. Maisel & James L. JanuzziJrJr. (2015) State of the Art: Newer biomarkers in heart failure. European Journal of Heart Failure 17:6, pages 559-569.
Crossref
Crossref
Fei Fei, Eun Ji Joo, Somayeh S. Tarighat, Isabelle Schiffer, Helicia Paz, Muller Fabbri, Hisham Abdel-Azim, John Groffen & Nora Heisterkamp. (2015) B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget 6:13, pages 11378-11394.
Crossref
Crossref
Mando D. Filipe, Wouter C. Meijers, A. Rogier van der Velde & Rudolf A. de Boer. (2015) Galectin-3 and heart failure: Prognosis, prediction & clinical utility. Clinica Chimica Acta 443, pages 48-56.
Crossref
Crossref
Francisco Javier Carrasco-Sánchez & María Inmaculada Páez-Rubio. (2014) Review of the Prognostic Value of Galectin-3 in Heart Failure Focusing on Clinical Utility of Repeated Testing. Molecular Diagnosis & Therapy 18:6, pages 599-604.
Crossref
Crossref
Rudolf A. de Boer, A. Rogier van der Velde, Christian Mueller, Dirk J. van Veldhuisen, Stefan D. Anker, W. Frank Peacock, Kirkwood F. Adams & Alan Maisel. (2014) Galectin-3: A Modifiable Risk Factor in Heart Failure. Cardiovascular Drugs and Therapy 28:3, pages 237-246.
Crossref
Crossref